The potential therapeutic applications of RNAi wererealized almost immediately after the phenomenon was first described; over theyears, developers have gradually progressed their proprietary drug candidateswith cautious optimism
Roots Analysis is pleased to announce the publication of its recentstudy, titled, “RNAiTherapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA, miRNA, shRNAand DNA.”
The “RNAi Therapeutics Market (2nd Edition), 2019-2030:Focus On siRNA, miRNA, shRNA and DNA” report features an extensive study of thecurrent market landscape and future opportunities associated with RNAitherapeutics. The study also features a detailed analysis of key drivers andtrends within this evolving market. Amongst other elements, the report includes:
To order this 285+ page report, which features 100+ figuresand 110+ tables, please visit this
https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html
§ Adetailed assessment of the current market landscape of drug developers engagedin the development of RNAi therapeutics.
§ Acompetitiveness analysis of key players engaged in this domain, evaluatingtheir respective product portfolios, type of RNAi molecule, target therapeuticareas, company size and year of establishment
§ Adetailed analysis of more than 70 completed, ongoing and planned clinicalstudies of RNAi therapeutics.
§ Adetailed analysis of various patents that have been filed / granted related toRNAi therapeutics, since 2014
§ Ananalysis of the partnerships that have been established in this domain, in therecent past.
§ Ananalysis of the investments made at various stages of development in companiesengaged in this domain.
§ Ananalysis of the key promotional strategies that have been adopted by developersof marketed oligonucleotide therapeutics, namely Defitelio®, Exondys® andOnpattro®.
§ Detailedprofiles of RNAi Therapeutics that are in the late stage clinical development
§ A detailed market forecast, featuring analysis of the currentand projected future opportunity across key market segments (listed below)
- Key Therapeutic Areas
§ Oncologicaldisorders
§ Infectiousdiseases
§ Geneticdisorders
§ Ophthalmicdisorders
§ Hepaticdisorders
§ Respiratorydisorders
- Type of RNAi molecule
§ siRNA
§ miRNA
§ shRNA
§ sshRNA
§ DNA
- Route of administration
§ Subcutaneous
§ Intravenous
§ Intradermal
§ Intravitreal
§ Oral
§ Intramuscular
- Key geographical regions
§ NorthAmerica
§ Europe
§ AsiaPacific and the Rest of the world
- Leading Player
To request a sample copy / brochure of this report, please visitthis- https://www.rootsanalysis.com/reports/295/request-sample.html
Keycompanies covered in the report
§ QuarkPharmaceuticals
§ AlnylamPharmaceuticals
§ DicernaPharmaceuticals
§ SouzhouRibo Life Sciences
§ OlixPharmaceuticals
§ Sirnaomics
§ ArizPrecision Medicine
§ ArrowheadPharmaceuticals
§ Gradalis
§ BenitecBiopharma
Formore information please click on the following link:
Other Recent Offerings
1. Gene Therapy Market (3rdEdition), 2019-2030
2. Global T-Cell (CAR-T,TCR and TIL) Therapy Market (4th Edition), 2019-2030
3. BiopharmaContract Manufacturing Market (3rd Edition), 2019-2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
